Style | Citing Format |
---|---|
MLA | Shakeran Z, et al.. "Biodegradable Nanocarriers Based on Chitosan-Modified Mesoporous Silica Nanoparticles for Delivery of Methotrexate for Application in Breast Cancer Treatment." Materials Science and Engineering C, vol. 118, no. , 2021, pp. -. |
APA | Shakeran Z, Keyhanfar M, Varshosaz J, Sutherland DS (2021). Biodegradable Nanocarriers Based on Chitosan-Modified Mesoporous Silica Nanoparticles for Delivery of Methotrexate for Application in Breast Cancer Treatment. Materials Science and Engineering C, 118(), -. |
Chicago | Shakeran Z, Keyhanfar M, Varshosaz J, Sutherland DS. "Biodegradable Nanocarriers Based on Chitosan-Modified Mesoporous Silica Nanoparticles for Delivery of Methotrexate for Application in Breast Cancer Treatment." Materials Science and Engineering C 118, no. (2021): -. |
Harvard | Shakeran Z et al. (2021) 'Biodegradable Nanocarriers Based on Chitosan-Modified Mesoporous Silica Nanoparticles for Delivery of Methotrexate for Application in Breast Cancer Treatment', Materials Science and Engineering C, 118(), pp. -. |
Vancouver | Shakeran Z, Keyhanfar M, Varshosaz J, Sutherland DS. Biodegradable Nanocarriers Based on Chitosan-Modified Mesoporous Silica Nanoparticles for Delivery of Methotrexate for Application in Breast Cancer Treatment. Materials Science and Engineering C. 2021;118():-. |
BibTex | @article{ author = {Shakeran Z and Keyhanfar M and Varshosaz J and Sutherland DS}, title = {Biodegradable Nanocarriers Based on Chitosan-Modified Mesoporous Silica Nanoparticles for Delivery of Methotrexate for Application in Breast Cancer Treatment}, journal = {Materials Science and Engineering C}, volume = {118}, number = {}, pages = {-}, year = {2021} } |
RIS | TY - JOUR AU - Shakeran Z AU - Keyhanfar M AU - Varshosaz J AU - Sutherland DS TI - Biodegradable Nanocarriers Based on Chitosan-Modified Mesoporous Silica Nanoparticles for Delivery of Methotrexate for Application in Breast Cancer Treatment JO - Materials Science and Engineering C VL - 118 IS - SP - EP - PY - 2021 ER - |